Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) Study
- 25 October 2006
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 152 (5), 860-866
- https://doi.org/10.1016/j.ahj.2006.01.013
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery diseaseEuropean Heart Journal, 2005
- Patterns of β-blocker utilization in patients with chronic heart failure: experience from a specialized outpatient heart failure clinicAmerican Heart Journal, 2004
- The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysisJournal of the American College of Cardiology, 2001
- Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II TrialCirculation, 2001
- beta Blockade after myocardial infarction: systematic review and meta regression analysisBMJ, 1999
- Recent Trends in Acute Coronary Heart Disease — Mortality, Morbidity, Medical Care, and Risk FactorsNew England Journal of Medicine, 1996
- Effects of Prophylactic Antiarrhythmic Drug Therapy in Acute Myocardial InfarctionJAMA, 1993
- Heart rate and cardiovascular mortality: The Framingham studyAmerican Heart Journal, 1987
- Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trialsThe American Journal of Cardiology, 1986
- Risk Stratification and Survival after Myocardial InfarctionNew England Journal of Medicine, 1983